A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT01900574 · COMPLETED
Trial details
- NCT number
- NCT01900574
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-09
- Primary completion
- 2015-02-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.